The Onset of Diabetes During Transcranial Direct Current Stimulation Treatment of Anorexia Nervosa - A Case Report

The relationship between tDCS (transcranial direct current stimulation) and its influence on glycemia has been the aim of limited research efforts. Usually, the focus has been set on lowering the blood sugar level or interference with insulin resistance, but also the treatment of diabetic polyneurop...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in psychiatry Vol. 11; p. 40
Main Authors Mares, Tadeas, Ceresnakova, Silvie, Albrecht, Jakub, Buday, Jozef, Klasova, Johana, Horackova, Klara, Raboch, Jiri, Papezova, Hana, Anders, Martin
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 13.02.2020
Subjects
adverse effect
anorexia nervosa
insulin resistance
Psychiatry
transcranial direct current stimulation
type 1 diabetes
type 1 diabetes
adverse effect
anorexia nervosa
insulin resistance
transcranial direct current stimulation
Online AccessGet full text

Cover

More Information
Summary:The relationship between tDCS (transcranial direct current stimulation) and its influence on glycemia has been the aim of limited research efforts. Usually, the focus has been set on lowering the blood sugar level or interference with insulin resistance, but also the treatment of diabetic polyneuropathy and pain management. In this case report, we outline the development of hyperglycemia and the following onset of type I diabetes during a series of tDCS in a 24-year old Caucasian female patient treated with our research protocol (10 sessions; 2 mA; 30 min; the anode over F3; the cathode over Fp2) for anorexia nervosa.
Bibliography:Reviewed by: Daniel Keeser, Ludwig Maximilian University of Munich, Germany; Helena Knotkova, MJHS Institute for Innovation in Palliative Care, United States
Edited by: Berthold Langguth, University of Regensburg, Germany
This article was submitted to Neuroimaging and Stimulation, a section of the journal Frontiers in Psychiatry
ISSN:1664-0640
1664-0640
DOI:10.3389/fpsyt.2020.00040